Klin Farmakol Farm. 2024;38(2):52-54 | DOI: 10.36290/far.2024.008

Evaluation of the incidence of unlicensed and off-label prescriptions in children

Petra Matalová1, Lucie Belfínová1, Kristýna Vrbicová1, Jana Fürstová2, Martin Wawruch3
1 Ústav farmakologie LF UP FN Olomouc
2 Katedra matematické analýzy a aplikací matematiky, Přírodovědecká fakulta UP Olomouc
3 Ústav farmakológie a klinickej farmakológie, Lekárska fakulta, Univerzita Komenského, Bratislava

Many common drugs have not been registered for use in children. Therefore, they are sometimes prescribed as unlicensed or off-label. This study, performed at the Department of Paediatrics, University Hospital Olomouc, Czech Republic, evaluated off-label and unlicensed prescriptions. A similar study, conducted in 2013 by the same authors (P. Matalová - maiden name P. Langerová), showed that the number of off-label and unlicensed prescriptions was relatively low, compared to other studies. The goal of this study was to compare the frequency of off-label and unlicensed drug prescriptions, and to assess whether these prescriptions have declined.

Keywords: children, prescriptions, off-label, unlicensed, paediatrics, comparison.

Accepted: June 28, 2024; Published: July 15, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matalová P, Belfínová L, Vrbicová K, Fürstová J, Wawruch M. Evaluation of the incidence of unlicensed and off-label prescriptions in children. Klin Farmakol Farm. 2024;38(2):52-54. doi: 10.36290/far.2024.008.
Download citation

References

  1. Waller DG. Off-label and unlicensed prescribing for children: have we made any progress? Br J Clin Pharmacol. 2007;64(1):1-2. Go to original source... Go to PubMed...
  2. Hoppu K, et al. The status of paediatric medicines initiatives around the world - What has happened and what has not? Eur J Clin Pharmacol. 2012; 68:1-10. Go to original source... Go to PubMed...
  3. Teigen A, Wang S, Truong BT, Bjerknes K. Off-label and unlicensed medicines to hospitalised children in Norway. J Pharm Pharmacol. 2017;69(4):432-438. Go to original source... Go to PubMed...
  4. Matalová P, Urbánek K, Anzenbacher P. Specific features of pharmacokinetics in children. Drug Metab Rev. 2016;48(1): 70-79. Go to original source... Go to PubMed...
  5. Langerová P, Vrtal J, Urbánek K. Incidence of unlicensed and off-label prescription in children. Ital J Pediatr. 2014; 40:12. Go to original source... Go to PubMed...
  6. Cuzzolin L, et al. Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study. Eur J Clin Pharmacol. 2016. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.